title: [Mechanism and overcome against drug resistance to imatinib for treatment of chronic myeloid leukemia].
authors.affiliation: Dept. of hematology, Tokyo Medical University, Tokyo, Japan
authors.forename: Tetsuzo
authors.initials: T
authors.lastname: Tauchi
authors.forename: Kazuma
authors.initials: K
authors.lastname: Oyashiki
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D019008:Drug Resistance, Neoplasm; D016044:Fusion Proteins, bcr-abl / Q000235:genetics; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism; D027702:Organic Cation Transporter 1 / Q000378:metabolism; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D027702:Organic Cation Transporter 1; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D016044:Fusion Proteins, bcr-abl